电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

TBC1D17 抗体 (AA 1-350)

This anti-TBC1D17 antibody is a 兔 多克隆 antibody detecting TBC1D17 in WB, ELISA, IHC 和 IF. Suitable for 人, 大鼠 和 小鼠.
产品编号 ABIN7119799
发货至: 中国

Quick Overview for TBC1D17 抗体 (AA 1-350) (ABIN7119799)

抗原

See all TBC1D17 抗体
TBC1D17 (TBC1 Domain Family, Member 17 (TBC1D17))

适用

  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
人, 大鼠, 小鼠

宿主

  • 2

克隆类型

  • 2
多克隆

标记

  • 2
This TBC1D17 antibody is un-conjugated

应用范围

Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
  • 抗原表位

    • 1
    • 1
    AA 1-350

    原理

    TBC1D17 antibody

    纯化方法

    Immunogen affinity purified

    纯度

    ≥95 % as determined by SDS-PAGE

    免疫原

    Immunogen sequence: 1-350aa

    Immunogen: TBC1 domain family, member 17

    亚型

    IgG
  • 应用备注

    WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:20-1:200

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    注意事项

    Avoid repeated freeze / thaw cycles.

    储存条件

    -20 °C

    储存方法

    -20°C for 12 months

    有效期

    12 months
  • 抗原

    TBC1D17 (TBC1 Domain Family, Member 17 (TBC1D17))

    别名

    TBC1D17

    背景

    Synonyms: TBC1 domain family member 17|TBC1D17

    Background: Probable GTPase-activating protein for Rab8, its transient association with Rab8 is mediated by OPTN. Inhibits Rab8-mediated endocytic trafficking, such as of transferrin receptor(TfR) and reduces Rab8 recruitnment to tubules emanating from the endocytic recycling compartment(ERC). Involved in regulation of autophagy. Mediates inhibition of autophagy caused by the OPTN variant GLC1E LYS-50, the function requires its catalytic activity, however, the involved Rab is not known.

    分子量

    73-100 kDa

    基因ID

    79735

    UniProt

    Q9HA65
You are here:
Chat with us!